The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The evaluation of endometrial thickness and bone mineral density based on CYP2D6 polymorphisims in Turkish breast cancer patients receiving tamoxifen treatment.
Meral Gunaldi
No relevant relationships to disclose
Melek Erkisi
No relevant relationships to disclose
Cigdem Usul Afsar
No relevant relationships to disclose
Vehbi Ercolak
No relevant relationships to disclose
Semra Paydas
No relevant relationships to disclose
Ismail Oguz Kara
No relevant relationships to disclose
Berksoy Sahin
No relevant relationships to disclose
Umran Gulec
No relevant relationships to disclose
Ata Secilmis
No relevant relationships to disclose